ACG Clinical Guideline: The Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury

被引:685
作者
Chalasani, Naga P. [1 ]
Hayashi, Paul H. [2 ]
Bonkovsky, Herbert L. [3 ]
Navarro, Victor J. [4 ]
Lee, William M. [5 ]
Fontana, Robert J. [6 ]
机构
[1] Indiana Univ Sch Med, Indianapolis, IN 46202 USA
[2] Univ N Carolina, Chapel Hill, NC USA
[3] CarolinasHealthCare Syst, Charlotte, NC USA
[4] Einstein Hlth Care Network, Philadelphia, PA USA
[5] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
[6] Univ Michigan, Ann Arbor, MI 48109 USA
基金
美国国家卫生研究院;
关键词
INTRAVENOUS N-ACETYLCYSTEINE; CAUSALITY ASSESSMENT; VENOOCCLUSIVE DISEASE; HEPATITIS-C; ADVERSE REACTIONS; AMERICAN-COLLEGE; HEPATOTOXICITY; OUTCOMES; FAILURE; METHOTREXATE;
D O I
10.1038/ajg.2014.131
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
Idiosyncratic drug-induced liver injury (DILI) is a rare adverse drug reaction and it can lead to jaundice, liver failure, or even death. Antimicrobials and herbal and dietary supplements are among the most common therapeutic classes to cause DILI in the Western world. DILI is a diagnosis of exclusion and thus careful history taking and thorough work-up for competing etiologies are essential for its timely diagnosis. In this ACG Clinical Guideline, the authors present an evidence-based approach to diagnosis and management of DILI with special emphasis on DILI due to herbal and dietary supplements and DILI occurring in individuals with underlying liver disease.
引用
收藏
页码:950 / 966
页数:17
相关论文
共 91 条
[1]
Important Elements for the Diagnosis of Drug-Induced Liver Injury [J].
Agarwal, Vijay K. ;
McHutchison, John G. ;
Hoofnagle, Jay H. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2010, 8 (05) :463-470
[2]
Drug-induced liver injury:: An analysis of 461 incidences submitted to the Spanish Registry over a 10-year period [J].
Andrade, RJ ;
Lucena, MI ;
Fernández, MC ;
Pelaez, G ;
Pachkoria, K ;
García-Ruiz, E ;
García-Munoz, B ;
González-Grande, R ;
Pizarro, A ;
Durán, JA ;
Jiménez, M ;
Rodrigo, L ;
Romero-Gomez, M ;
Navarro, JM ;
Planas, R ;
Costa, J ;
Borras, A ;
Soler, A ;
Salmerón, J ;
Martin-Vivaldi, R .
GASTROENTEROLOGY, 2005, 129 (02) :512-521
[3]
Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis [J].
Athyros, Vasilios G. ;
Tziomalos, Konstantinos ;
Gossios, Thomas D. ;
Griva, Theodora ;
Anagnostis, Panagiotis ;
Kargiotis, Konstantinos ;
Pagourelias, Efstathios D. ;
Theocharidou, Eleni ;
Karagiannis, Asterios ;
Mikhailidis, Dimitri P. .
LANCET, 2010, 376 (9756) :1916-1922
[4]
A randomized controlled trial adding fluvastatin to peginterferon and ribavirin for naive genotype 1 hepatitis C patients [J].
Bader, T. ;
Hughes, L. D. ;
Fazili, J. ;
Frost, B. ;
Dunnam, M. ;
Gonterman, A. ;
Madhoun, M. ;
Aston, C. E. .
JOURNAL OF VIRAL HEPATITIS, 2013, 20 (09) :622-627
[5]
Cytokeratin 18-based modification of the MELD score improves prediction of spontaneous survival after acute liver injury [J].
Bechmann, Lars P. ;
Jochum, Christoph ;
Kocabayoglu, Peri ;
Sowa, Jan-Peter ;
Kassalik, Marco ;
Gieseler, Robert K. ;
Saner, Fuat ;
Paul, Andreas ;
Trautwein, Christian ;
Gerken, Guido ;
Canbay, Ali .
JOURNAL OF HEPATOLOGY, 2010, 53 (04) :639-647
[6]
CAUSALITY ASSESSMENT OF ADVERSE REACTIONS TO DRUGS .2. AN ORIGINAL MODEL FOR VALIDATION OF DRUG CAUSALITY ASSESSMENT METHODS - CASE-REPORTS WITH POSITIVE RECHALLENGE [J].
BENICHOU, C ;
DANAN, G ;
FLAHAULT, A .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1993, 46 (11) :1331-1336
[7]
Reliability of the Roenigk classification of liver damage after methotrexate treatment for psoriasis [J].
Berends, Maartje A. M. ;
van Oijen, Martijn G. H. ;
Snoek, Josje ;
de Kerkhof, Peter C. M. van ;
Drenth, Joost P. H. ;
van Krieken, J. Han ;
de Jong, Elke M. G. J. .
ARCHIVES OF DERMATOLOGY, 2007, 143 (12) :1515-1519
[8]
Acute liver failure [J].
Bernal, William ;
Auzinger, Georg ;
Dhawan, Anil ;
Wendon, Julia .
LANCET, 2010, 376 (9736) :190-201
[9]
The impact of eosinophilia and hepatic necrosis on prognosis in patients with drug-induced liver injury [J].
Bjornsson, E. ;
Kalaitzakis, E. ;
Olsson, R. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 25 (12) :1411-1421
[10]
Incidence, Presentation, and Outcomes in Patients With Drug-Induced Liver Injury in the General Population of Iceland [J].
Bjornsson, Einar S. ;
Bergmann, Ottar M. ;
Bjornsson, Helgi K. ;
Kvaran, Runar B. ;
Olafsson, Sigurdur .
GASTROENTEROLOGY, 2013, 144 (07) :1419-U168